Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Clinical & Laboratory Research|January 1, 1995
Asparaginase decreases clotting factors in vitro: a possible pitfall?U Nowak-Göttl, J Boos, J E Wolff, et al.
British Journal of Haematology|March 1, 1997
Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemiaE Ahlke, U Nowak-Göttl, P Schulze-Westhoff, et al.
Blood Cells, Molecules & Diseases|January 30, 2017
Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotypeD Boeckelmann, H Hengartner, A Greinacher, et al.
Pneumologie (Stuttgart, Germany)|September 17, 1998
[Dyspnea and lung function. Results of a multicenter study]W Droszcz, A Doboszynska, E Pleger, et al.
European Heart Journal|January 29, 2002
Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in menG Benze, J Heinrich, H Schulte, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 1998
Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancerA H Groll, G Just-Nuebling, M Kurz, et al.
Thrombosis and Haemostasis|March 15, 2001
Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factorsC Escuriola Ettingshausen, S Halimeh, K Kurnik, et al.
Epilepsia|January 1, 1992
Valproate therapy induces von Willebrand disease type IW Kreuz, R Linde, M Funk, et al.
Pediatrics|June 1, 1997
Lipoprotein (a): its role in childhood thromboembolismU Nowak-Göttl, O Debus, M Findeisen, et al.
Blood Cells, Molecules & Diseases|January 15, 2017
Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonatesT Strauss, N Elisha, B Ravid, et al.
Pageof 14